Soiken Holdings Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 65

Employees

  • Stock Symbol
  • 2385

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.32
  • (As of Monday Closing)

Soiken Holdings General Information

Description

Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.

Contact Information

Website
www.soiken.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 13th floor, Senri Life Science Center
  • 1-4-2 Shin-Senri Higashi-machi
  • Toyonaka, Osaka 560-0082
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • 13th floor, Senri Life Science Center
  • 1-4-2 Shin-Senri Higashi-machi
  • Toyonaka, Osaka 560-0082
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Soiken Holdings Stock Performance

As of 16-Nov-2026, Soiken Holdings’s stock price is $1.32. Its current market cap is $34.5M with 26.2M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.32 $1.32 $1.23 - $2.08 $34.5M 26.2M 289K $0.05

Soiken Holdings Financials Summary

As of 30-Jun-2026, Soiken Holdings has a trailing 12-month revenue of $25.1M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV (446) (446) (4,316) (3,438)
Revenue 25,071 25,071 32,393 34,593
EBITDA 1,498 1,498 (1,373) (3,943)
Net Income 1,375 1,375 (1,408) (4,441)
Total Assets 42,314 42,314 47,131 43,165
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Soiken Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Soiken Holdings‘s full profile, request access.

Request a free trial

Soiken Holdings Patents

Soiken Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2011125326-A Method and evaluation kit for evaluating state of muscle fatigue and method for evaluating prevention and recovery effect for muscle fatigue possessed by substance Inactive 15-Dec-2009
JP-2009031280-A Method for evaluating degree of fatigue and its use Pending 29-Jun-2007
JP-2008094787-A Sympathetic nerve stimulant using peanut-treated material Pending 13-Oct-2006

Soiken Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Soiken Holdings Investments & Acquisitions (3)

Soiken Holdings’s most recent deal was a Later Stage VC with Medifellow. The deal was made on 18-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Medifellow 18-Jun-2025 Later Stage VC Clinics/Outpatient Services
NRL Pharma 01-Jun-2017 Merger/Acquisition Drug Discovery
TransAsia 12-Sep-2014 Secondary Transaction - Private Media and Information Services (B2B)
To view Soiken Holdings’s complete investments and acquisitions history, request access »

Soiken Holdings ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Laboratory Equipment and Services

Subindustry

Rank

Percentile

To view Soiken Holdings’s complete esg history, request access »

Soiken Holdings Affiliates

Subsidiaries (3)

Name Industry Location Year Founded
NRL Pharma Kawasaki, Japan 1998
Nihon Preventive Medicine Osaka, Japan 1996
Bb Laboratories Tokyo, Japan

Soiken Holdings FAQs

  • When was Soiken Holdings founded?

    Soiken Holdings was founded in 1994.

  • Where is Soiken Holdings headquartered?

    Soiken Holdings is headquartered in Toyonaka, Japan.

  • What is the size of Soiken Holdings?

    Soiken Holdings has 65 total employees.

  • What industry is Soiken Holdings in?

    Soiken Holdings’s primary industry is Biotechnology.

  • Is Soiken Holdings a private or public company?

    Soiken Holdings is a Public company.

  • What is Soiken Holdings’s stock symbol?

    The ticker symbol for Soiken Holdings is 2385.

  • What is the current stock price of Soiken Holdings?

    As of 16-Nov-2026 the stock price of Soiken Holdings is $1.32.

  • What is the current market cap of Soiken Holdings?

    The current market capitalization of Soiken Holdings is $34.5M.

  • What is Soiken Holdings’s current revenue?

    The trailing twelve month revenue for Soiken Holdings is $25.1M.

  • What is Soiken Holdings’s annual earnings per share (EPS)?

    Soiken Holdings’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process